MIDD: stop guessing, start modeling.

MIDD transforms drug development: predictive modeling, optimized dose selection, and stronger regulatory dialogue — from the earliest stages of development.

10 good reasons to use Modeling and Simulation in your drug development

Modeling expertise is an essential cornerstone for a robust and optimal drug development strategy.

FDA announces plan to phase out animal testing requirement for mAbs and other drugs

The FDA is taking a groundbreaking step to advance public health by replacing animal testing in the development of mAbs therapies and other drugs.